InsidersTradesSigma
Follow the Anthem Biosciences stock price and the full insider trade history of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Market capitalisation: €505.9bn. The latest transaction was filed on 16 July 2026 (Disposal). Among the most active insiders: Aruna Ganesh. The full history is free.
Analysts rate Anthem Biosciences Strong Buy (bullish), based on 8 analysts. Average price target: ₹905.13.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Anthem Biosciences 是一家生物技术公司，为创新健康解决方案提供研发服务。该公司在 XBOM 市场运营。